SPRING Vision is developing a technology for noninvasive, real-time, multispectral retinal imaging for automated diagnostics of ocular and systemic diseases.

The technology allows physicians to better differentiate between healthy and early-stage diseased retinal blood vessels.

In addition to large and small retinal and choroidal blood vessel detection, an additional novel technology is evaluated for portraying a retinal oxygenation map.

Coupled with AI, the above capabilities are likely to transform the practice of modern-day medicine.Microangiography, combined with retinal tissue oximetry (under clinical investigation), is expected to revolutionize the diagnostic ability and clinical application of retinal imaging, leading to a better forecast of retinal and systemic diseases through retinal imaging.The iCapture45 is a non-mydriatic and mydriatic multispectral retinal imager with a 45 degree field of view that uses SPRING Visions proprietary technology.

SPRING Vision is working on the upcoming iCapture75, a mydriatic imager with a larger field of view.